A randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Patients who meet the diagnostic criteria of ckd2-4 and grade 1-2 of acute kidney injury;
•2. Patients who meet the TCM syndrome diagnostic criteria of spleen and kidney deficiency and toxin and blood stasis syndrome;
•3. 24h U-pro <= 2.5g;
•4. Patients aged from 18 to 75 years old;
•5. Patients voluntarily participate in the clinical trial and sign the informed consent.

•1. Pregnant women or women preparing for pregnancy and lactation;
•2. Patients with severe primary diseases of other organs and in urgent need of immediate treatment, or with consumptive system diseases such as malignant tumor and active tuberculosis;
•3. Patients after renal transplantation;
•4. Patients with mental illness and those who can't cooperate with each other;
•5. Patients who are allergic to treatment drugs;
•6. Patients who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.

发起方